ADGRG4 and Miyoshi myopathy: Patients in the MM group had longer median OS compared with those in the WW group (35.70 versus 24.67 months; HR = 0.37, P = 0.009) and MW group, that is patients with mutated BRAF but wild-type GPR112 (35.70 versus 31.85 months; HR = 0.45, P = 0.050).